Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery
Status:
Withdrawn
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
The CATCH-enoxaparin trial is the natural continuation of the CATCH study. It will capitalize
on the fact that patients enrolled in the CATCH study will be specifically screened for
asymptomatic thromboembolism (TEs) in order to answer important clinical questions.
The investigators propose a randomized controlled trial to address whether, among pediatric
patients with congenital heart defects (CHD) recovering from cardiovascular surgery and
diagnosed with an asymptomatic venous TE, the use of enoxaparin results in a net therapeutic
benefit?